Taken together, these data indicated that ectopic expression of BRD4 contributed to the occurrence of tumour and was associated with a poorer prognosis in patients with NB, revealing that BRD4 could be an important therapeutic target in patients with NB. Here, BRD4 is linked to neuroblastoma.